相关实验视频

Updated: Jun 20, 2025

Feeder-free Derivation of Melanocytes from Human Pluripotent Stem Cells

Feeder-free Derivation of Melanocytes from Human Pluripotent Stem Cells

Published on: March 3, 2016

使用患者衍生诱导的多能干干细胞揭示了 xeroderma pigmentosum A 组中黑色素细胞的紫外线反应

Chihiro Takemori¹, Michiyo Koyanagi-Aoi², Takeshi Fukumoto¹

¹Division of Dermatology, Department of Internal Related, Graduate School of Medicine, Kobe University, Kobe, Japan.

Journal of dermatological science

|July 20, 2024

概括

黑色素体群A (XP-A) 患者的黑色素细胞显示DNA修复受损和基因表达改变,包括细胞因子通路升调,即使在低紫外线暴露后. 诱导多能干细胞 (iPSCs) 为研究XP-A病变发生和开发治疗方法提供了一个模型.

科学领域:

皮肤病学皮肤病学
遗传学遗传学是一个
干细胞生物学干细胞生物学

背景情况:

Xeroderma pigmentosum (XP) 涉及DNA修复缺陷,导致光敏感性,色素障碍和皮肤癌风险.
XP组A (XP-A) 患者表现出特征性的色素变化,需要由于光敏感性而严格防晒.
建立初级黑色素细胞 (MCs) 进行研究是具有挑战性的,阻碍了XP-A病变的研究.

研究的目的:

通过比较来自XP-A诱导多能干细胞 (iPSCs) 的黑色细胞和来自健康对照的黑色细胞来阐明XP-A的致病性.
在基因表达水平上分析XP-A黑色素细胞对紫外线照射的反应.

主要方法:

从XP-A纤维细胞中建立了iPSC,并将其分化为黑色素细胞 (XP-A-iMCs).
在UV-B照射 (30或150J/m2) 后,XP-A-iMCs和健康对照 iPSC衍生的黑色素细胞 (HC-iMCs) 的基因表达特征进行比较.
利用微阵列分析来评估基因表达变化,辐射后4小时和12小时.

主要成果:

XP-A-iMCs表现出特有的黑色素细胞标记物 (SOX10,MITF,TYR) 和黑色素合成.
与HC-iMCs相比,XP-A-iMCs显示DNA修复能力降低.
紫外线B辐射 (150 J/m2) 导致XP-A-iMCs基因表达发生显著,持久的变化,对细胞亡和细胞因子相关途径进行上调,即使在较低剂量 (30 J/m2) 中也是如此.

结论:

即使在低剂量紫外线暴露后,XP-A黑色素细胞中与细胞因子相关的通路也被上调,这是一个新发现.
疾病特异性的iPSC是了解XP病变的宝贵工具.
来自iPSC的黑色素细胞有助于开发XP的治疗策略.

关键词:

修复DNA的修复DNA的修复黑色素细胞黑色素细胞微阵列的微阵列紫外线辐射的紫外线辐射.黑色皮肤菌 (Xeroderma pigmentosum) 是一种有色素的植物.iPS 细胞细胞 iPS 细胞

更多相关视频

Direct Reprogramming of Mouse Fibroblasts into Melanocytes

Direct Reprogramming of Mouse Fibroblasts into Melanocytes

Published on: August 27, 2021

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

相关概念视频

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...